These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 35977610)

  • 1. Reply to: "Seladelpar in patients with primary biliary cholangitis: Need for a closer look!".
    Bowlus CL; Levy C; Hirschfield GM
    J Hepatol; 2022 Nov; 77(5):1452-1453. PubMed ID: 35977610
    [No Abstract]   [Full Text] [Related]  

  • 2. Seladelpar in patients with primary biliary cholangitis: Need for a closer look!
    Mishra AK; Singh SP
    J Hepatol; 2022 Nov; 77(5):1451. PubMed ID: 35594993
    [No Abstract]   [Full Text] [Related]  

  • 3. Seladelpar: an investigational drug for the treatment of early-stage primary biliary cholangitis (PBC).
    Wetten A; Jones DEJ; Dyson JK
    Expert Opin Investig Drugs; 2022 Oct; 31(10):1101-1107. PubMed ID: 36194037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study.
    Jones D; Boudes PF; Swain MG; Bowlus CL; Galambos MR; Bacon BR; Doerffel Y; Gitlin N; Gordon SC; Odin JA; Sheridan D; Wörns MA; Clark V; Corless L; Hartmann H; Jonas ME; Kremer AE; Mells GF; Buggisch P; Freilich BL; Levy C; Vierling JM; Bernstein DE; Hartleb M; Janczewska E; Rochling F; Shah H; Shiffman ML; Smith JH; Choi YJ; Steinberg A; Varga M; Chera H; Martin R; McWherter CA; Hirschfield GM
    Lancet Gastroenterol Hepatol; 2017 Oct; 2(10):716-726. PubMed ID: 28818518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seladelpar improved measures of pruritus, sleep, and fatigue and decreased serum bile acids in patients with primary biliary cholangitis.
    Kremer AE; Mayo MJ; Hirschfield G; Levy C; Bowlus CL; Jones DE; Steinberg A; McWherter CA; Choi YJ
    Liver Int; 2022 Jan; 42(1):112-123. PubMed ID: 34403559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reply to: "Chronic fatigue should not be overlooked in primary biliary cholangitis".
    Corpechot C
    J Hepatol; 2021 Sep; 75(3):745. PubMed ID: 34107290
    [No Abstract]   [Full Text] [Related]  

  • 7. Recognizing primary biliary cirrhosis and primary sclerosing cholangitis.
    Buckley SE; DiPalma JA
    Am Fam Physician; 1996 Jan; 53(1):195-200. PubMed ID: 8546046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary sclerosing cholangitis.
    Lefkowitch JH; Martin EC
    Prog Liver Dis; 1986; 8():557-80. PubMed ID: 3520670
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary biliary cholangitis in a patient with metastatic breast cancer.
    Doello K; Rueda MT; Amezcua V
    Med Clin (Barc); 2021 Feb; 156(3):146. PubMed ID: 32107045
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunohistochemical differences in the portal tract and acinar infiltrates between primary biliary cirrhosis and autoimmune cholangitis.
    O'Donohue J; Wong T; Portmann B; Williams R
    Eur J Gastroenterol Hepatol; 2002 Oct; 14(10):1143-50. PubMed ID: 12362106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing Nomenclature for PBC from "Primary Biliary Cirrhosis" to "Primary Biliary Cholangitis".
    Tanaka A; Takikawa H; Mochida S; Koike K; Miwa H; Shimosegawa T
    J Gastroenterol; 2016 Jul; 51(7):748-9. PubMed ID: 27230619
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary Hepatic Mucosa-Associated Lymphoid Tissue Lymphoma in a Patient with Primary Biliary Cholangitis.
    Hamada K; Yamamoto S; Seno H
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):e352-e353. PubMed ID: 33677076
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary Biliary Cholangitis and Autoimmune Hepatitis.
    Gonzalez RS; Washington K
    Surg Pathol Clin; 2018 Jun; 11(2):329-349. PubMed ID: 29751878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune liver disease (primary biliary cholangitis/autoimmune hepatitis-overlap) associated with sarcoidosis (clinical cases and literature review).
    Burnevich ES; Popova EN; Ponomarev AB; Nekrasova TP; Lebedeva MV; Filatova AL; Shchanitcyna EM; Ponomareva LA; Beketov VD; Bondarenko IB; Tanashchuk EL; Nikulkina EN; Moiseev SV
    Ter Arkh; 2019 Mar; 91(1):89-94. PubMed ID: 31090378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary biliary cirrhosis and primary sclerosing cholangitis.
    Angulo P; Lindor KD
    Clin Liver Dis; 1999 Aug; 3(3):529-70. PubMed ID: 11291238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary sclerosing cholangitis and ulcerative colitis.
    Mörl M; Classen M
    Acta Hepatogastroenterol (Stuttg); 1975 Dec; 22(6):415-9. PubMed ID: 1211068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis.
    Floreani A; Motta R; Cazzagon N; Franceschet I; Roncalli M; Del Ross T; Rosina F; Lleo A; Mescoli C; Colloredo G; Invernizzi P
    Dig Liver Dis; 2015 May; 47(5):432-5. PubMed ID: 25747115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-existence of primary biliary cirrhosis and primary sclerosing cholangitis: a rare overlap syndrome put in perspective.
    Kingham JG; Abbasi A
    Eur J Gastroenterol Hepatol; 2005 Oct; 17(10):1077-80. PubMed ID: 16148553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis.
    Sarcognato S; Sacchi D; Grillo F; Cazzagon N; Fabris L; Cadamuro M; Cataldo I; Covelli C; Mangia A; Guido M
    Pathologica; 2021 Jun; 113(3):170-184. PubMed ID: 34294935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sclerosing cholangitis and primary biliary cirrhosis--a disease spectrum?
    Fee HJ; Gewirtz H; Schiller J; Longmire WP
    Ann Surg; 1977 Nov; 186(5):589-93. PubMed ID: 921353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.